These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

728 related items for PubMed ID: 15359376

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.
    Staner L, Boeijinga P, Danel T, Gendre I, Muzet M, Landron F, Luthringer R.
    Alcohol Clin Exp Res; 2006 Sep; 30(9):1492-9. PubMed ID: 16930211
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sleep electroencephalographic spectral power after withdrawal from alcohol in alcohol-dependent patients.
    Feige B, Scaal S, Hornyak M, Gann H, Riemann D.
    Alcohol Clin Exp Res; 2007 Jan; 31(1):19-27. PubMed ID: 17207097
    [Abstract] [Full Text] [Related]

  • 7. The effect of placebo administration on the first-night effect in healthy young volunteers.
    Suetsugi M, Mizuki Y, Yamamoto K, Uchida S, Watanabe Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May 09; 31(4):839-47. PubMed ID: 17328999
    [Abstract] [Full Text] [Related]

  • 8. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
    Walsh JK, Thacker S, Knowles LJ, Tasker T, Hunneyball IM.
    Sleep Med; 2009 Sep 09; 10(8):859-64. PubMed ID: 19345644
    [Abstract] [Full Text] [Related]

  • 9. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
    Reoux JP, Saxon AJ, Malte CA, Baer JS, Sloan KL.
    Alcohol Clin Exp Res; 2001 Sep 09; 25(9):1324-9. PubMed ID: 11584152
    [Abstract] [Full Text] [Related]

  • 10. Self-reported sleep, sleepiness, and repeated alcohol withdrawals: a randomized, double blind, controlled comparison of lorazepam vs gabapentin.
    Malcolm R, Myrick LH, Veatch LM, Boyle E, Randall PK.
    J Clin Sleep Med; 2007 Feb 15; 3(1):24-32. PubMed ID: 17557449
    [Abstract] [Full Text] [Related]

  • 11. The effects of clomethiazole on polysomnographically recorded sleep in healthy subjects.
    Gann H, Hartig K, Feige B, Brueck R, Hohagen F, Weske G, van Calker D, Riemann D.
    Eur Arch Psychiatry Clin Neurosci; 2005 Aug 15; 255(4):284-90. PubMed ID: 15864407
    [Abstract] [Full Text] [Related]

  • 12. Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study.
    Fernandez HH, Okun MS, Rodriguez RL, Malaty IA, Romrell J, Sun A, Wu SS, Pillarisetty S, Nyathappa A, Eisenschenk S.
    Int J Neurosci; 2009 Aug 15; 119(12):2196-205. PubMed ID: 19916848
    [Abstract] [Full Text] [Related]

  • 13. Ingestion of ethanol just prior to sleep onset impairs memory for procedural but not declarative tasks.
    Smith C, Smith D.
    Sleep; 2003 Mar 15; 26(2):185-91. PubMed ID: 12683478
    [Abstract] [Full Text] [Related]

  • 14. Oxcarbazepine--efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot study.
    Koethe D, Juelicher A, Nolden BM, Braunwarth WD, Klosterkötter J, Niklewski G, Wodarz N, Klatt J, Burtscheidt W, Gaebel W, Markus Leweke F.
    Alcohol Clin Exp Res; 2007 Jul 15; 31(7):1188-94. PubMed ID: 17511748
    [Abstract] [Full Text] [Related]

  • 15. A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients.
    Hajak G, Hedner J, Eglin M, Loft H, Stórustovu SI, Lütolf S, Lundahl J, Gaboxadol Study 99775 Group.
    Sleep Med; 2009 Aug 15; 10(7):705-12. PubMed ID: 19346160
    [Abstract] [Full Text] [Related]

  • 16. Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam.
    Greenblatt DJ, Harmatz JS, Zinny MA, Shader RI.
    N Engl J Med; 1987 Sep 17; 317(12):722-8. PubMed ID: 3306380
    [Abstract] [Full Text] [Related]

  • 17. The effects of mirtazapine on sleep: a placebo controlled, double-blind study in young healthy volunteers.
    Aslan S, Isik E, Cosar B.
    Sleep; 2002 Sep 15; 25(6):677-9. PubMed ID: 12224847
    [Abstract] [Full Text] [Related]

  • 18. Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations.
    Le Bon O, Murphy JR, Staner L, Hoffmann G, Kormoss N, Kentos M, Dupont P, Lion K, Pelc I, Verbanck P.
    J Clin Psychopharmacol; 2003 Aug 15; 23(4):377-83. PubMed ID: 12920414
    [Abstract] [Full Text] [Related]

  • 19. Effect of intravenous magnesium sulphate in reducing irritability and restlessness in pure and polysubstance opiate detoxification.
    Naderi-Heiden A, Frey R, Presslich O, Frottier P, Willinger U, Blasbichler T, Smetana R, Schmid D, Kasper S.
    Psychiatry Res; 2005 May 15; 135(1):53-63. PubMed ID: 15893381
    [Abstract] [Full Text] [Related]

  • 20. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.
    Riemann D, Voderholzer U, Cohrs S, Rodenbeck A, Hajak G, Rüther E, Wiegand MH, Laakmann G, Baghai T, Fischer W, Hoffmann M, Hohagen F, Mayer G, Berger M.
    Pharmacopsychiatry; 2002 Sep 15; 35(5):165-74. PubMed ID: 12237787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.